Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | LAP3 | P28838 | 2/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 3/20 | 0.44 |
| ▸ | KYNU | Q16719 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21189144 | 1.00 | ALDH1A1 (0.45) | ALDH1A1LAP3SLC1A3SLC1A1LTA4H | |
| Methyl Alcohol SCHEMBL28469240 | 0.84 | S1PR2 (0.48) | ALDH1A1LAP3IDO1 | |
| SCHEMBL21189175 | 0.84 | S1PR2 (0.50) | ALDH1A1LAP3SLC1A3SLC1A1IDO1 | |
| SCHEMBL21189149 | 0.82 | ALDH1A1 (0.43) | ALDH1A1LTA4HMAPK1L3MBTL1KMT2A | |
| SCHEMBL21189148 | 0.82 | ALDH1A1 (0.43) | ALDH1A1LTA4HMAPK1L3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL27452128 | 0.80 | LTA4H (0.56) | ALDH1A1LAP3SLC1A3SLC1A1LTA4H | |
| SCHEMBL12869905 | 0.79 | ALDH1A1 (0.53) | ALDH1A1LAP3SLC1A3SLC1A1LTA4H | |
| SCHEMBL3096935 | 0.79 | ALDH1A1 (0.53) | ALDH1A1LAP3SLC1A3SLC1A1LTA4H | |
| SCHEMBL21174075 | 0.79 | KYNU (0.59) | ALDH1A1KYNU | |
| SCHEMBL21174135 | 0.79 | KYNU (0.59) | ALDH1A1KYNU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10774098-B2 | Nahlsgen optical resolution method | KYOTO UNIVERSITY (JP) | 2020-09-15 | — | — | US | disclosed |
| US-20190225634-A1 | NAHLSGEN OPTICAL RESOLUTION METHOD | KYOTO UNIVERSITY (JP) | 2019-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10774098-B2 | Nahlsgen optical resolution method | HACL2, HAO2, HPD | ALDH1A1 150/4885LAP3 1325/4885SLC1A3 816/4885 |
| US-20190225634-A1 | NAHLSGEN OPTICAL RESOLUTION METHOD | HACL2, HAO2, HPD | ALDH1A1 150/4885LAP3 1325/4885SLC1A3 816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.